Coston, Mc Isaac & Partners Northwest Biotherapeutics Inc Transaction History
Coston, Mc Isaac & Partners
- $259 Million
- Q1 2024
A detailed history of Coston, Mc Isaac & Partners transactions in Northwest Biotherapeutics Inc stock. As of the latest transaction made, Coston, Mc Isaac & Partners holds 1,000 shares of NWBO stock, worth $420. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$420
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NWBO
# of Institutions
12Shares Held
625KCall Options Held
0Put Options Held
0-
Moloney Securities Asset Management, LLC379KShares$159,3730.03% of portfolio
-
Opus Capital Group, LLC60.2KShares$25,2630.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY40KShares$16,8000.0% of portfolio
-
Maripau Wealth Management LLC Fort Wayne, IN39.5KShares$16,5870.02% of portfolio
-
Ethos Financial Group, LLC King Of Prussia, PA23.7KShares$9,9540.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $436M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...